title: The Effect of Enzalutamide and Bicalutamide on Patient-reported Quality of Life Outcomes: Results from the TERRAIN Study.
authors.affiliation: Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: mark.tyson@vanderbilt.edu.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Tyson
authors.affiliation: Division of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.
authors.forename: Alan
authors.initials: A
authors.lastname: Bryce
mesh_terms: D000813:Anilides; D001549:Benzamides; D006801:Humans; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives; D011471:Prostatic Neoplasms; D011788:Quality of Life; D014105:Tosyl Compounds
chemical_list: D000813:Anilides; D001549:Benzamides; D009570:Nitriles; D014105:Tosyl Compounds; D010669:Phenylthiohydantoin; C540278:enzalutamide